Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Multi-center Pasireotide Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Pasireotide Study and Are Judged by the Investigator to Benefit From Continued Pasireotide Treatment

NCT01794793 is registered in ClinicalTrials.gov with RECORDATI GROUP as lead sponsor.

NCT NCT01794793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01794793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Multi-center Pasireotide Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Pasireotide Study and Are Judged by the Investigator to Benefit From Continued Pasireotide Treatment
Lead sponsor
RECORDATI GROUP
Phase
Phase 4
Overall status
Completed
Start date
June 10, 2013
Completion date
July 25, 2023
Enrollment
337 (actual)
Sites
94

Conditions

As the registry lists them; a condition with its own page is linked.

acromegaly, cushing's disease, dumping syndrome, ectopic acth secreting (eas) tumors, melanoma negative for braf, melanoma negative for nras, neuroendocrine tumors, pituitary tumors, prostate cancer